Celldex Therapeutics (CLDX)

Add to Watchlists
Create an Alert
14.69 +0.96  +6.99% NASDAQ Apr 16, 8:00PM BATS Real time Currency in USD

Celldex Therapeutics Cash from Investing (Quarterly):

-13.82M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Celldex Therapeutics Cash from Investing (Quarterly) Chart

Export Data
Save Image

Celldex Therapeutics Historical Cash from Investing (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 -13.82M
Sept. 30, 2013 5.558M
June 30, 2013 -22.58M
March 31, 2013 -46.58M
Dec. 31, 2012 -4.537M
Sept. 30, 2012 5.987M
June 30, 2012 9.077M
March 31, 2012 -27.51M
Dec. 31, 2011 8.044M
Sept. 30, 2011 10.35M
June 30, 2011 -25.82M
March 31, 2011 5.27M
Dec. 31, 2010 7.512M
Sept. 30, 2010 2.078M
June 30, 2010 -18.22M
March 31, 2010 -7.536M
Dec. 31, 2009 44.68M
Sept. 30, 2009 -0.115M
June 30, 2009 -0.185M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

CLDX Cash from Investing (Quarterly) Benchmarks

Companies
Array BioPharma -14.96M
Alexion Pharmaceuticals -613.27M
Emergent BioSolutions -9.354M

CLDX Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -46.58M Mar 2013
Maximum 44.68M Dec 2009
Average -3.597M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.